856 records found.
Dec 13, 2019
MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping
Dec 12, 2019
European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Dec 12, 2019
Dry Eye, Dry Skin & Health Olympics Education Discussed On Sharon Kleyne Talk Radio
Dec 12, 2019
Global Somatostatin Analogs Industry Outlook, 2019-2026 - Pasireotide Estimated to Be the Fastest Growing Segment Over the Forecast Period
Dec 12, 2019
NetNoggin® releases exploratory analysis "Psychographics for TRIKAFTA(TM), the new treatment by Vertex for patients with cystic fibrosis."
Dec 12, 2019
Trumpet Shares 2019 Progress and Plans for Further Expansion in 2020
Dec 12, 2019
Trellis School launches their new Middle and High School Program in Sparks, MD
Dec 12, 2019
Significant Effect of Diamyd® in Type 1 Diabetes Shown in a New Comprehensive Analysis of Previous Phase III and Phase II Trials
Dec 11, 2019
Philip M. Gattone to Step Down as President & CEO of the Epilepsy Foundation
Dec 10, 2019
SmartSolutions RX Launches LOCKrx, A Drug-Free Support System Fighting To Keep Hair Thick and Healthy
Dec 10, 2019
Daavlin Partners with HealthLens to Increase Phototherapy Access for Patients
Dec 10, 2019
The global artificial ligaments and tendons market at a CAGR of over 11% during the forecast period
Dec 09, 2019
Global Spinal Cord Stimulation (SCS) Market 2019-2023: Rise in Adoption of Surgical Robots / Proclaim XR / 7D Surgical System / Attempts by Major Players to Strengthen Presence in the Market
Dec 09, 2019
Mistaken identity: Uncovering the Truth about 'Sebaceous' Cysts
Dec 09, 2019
Short Term Study of CBD Use Reports Zero Adverse Events
Dec 09, 2019
Muscular Dystrophy Association Names Sharon Hesterlee, Ph.D., Executive Vice President, Chief Research Officer
Dec 09, 2019
HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Dec 09, 2019
Eisai Presents New Seizure Freedom and Adherence Data Related to Anti-Epileptic Drug FYCOMPA® at the 2019 American Epilepsy Society Annual Meeting
Dec 08, 2019
Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated T-Cell Malignancies
Dec 06, 2019
Wave Neuroscience Completes Major Brain Treatment Technology Asset Purchase

Pages